Table 1. Demographic and Cancer-Specific Variables.
| Variable | Value (N = 83) |
|---|---|
| Age, y | |
| Mean (95% CI) | 59.54 (57.23-61.73) |
| Range | 34-86 |
| Sex, No. (%) | |
| Female | 19 (23) |
| Male | 64 (77) |
| Race, No. (%) | |
| White | 63 (76) |
| African American | 17 (20) |
| Other | 3 (4) |
| Education, y | |
| Mean (95% CI) | 13.78 (13.31-14.48) |
| Range | 9-21 |
| Employment at diagnosis, No. (%) | |
| Full or part time | 34 (41) |
| Retired | 30 (36) |
| Disability | 13 (16) |
| Marital status, No. (%) | |
| Married or partnered | 54 (65) |
| Single or divorced | 25 (30) |
| Widowed | 4 (5) |
| Sufficient social support, No. (%) | 75 (90) |
| American Joint Committee on Cancer stage, No. (%) | |
| Early (stage I-II) | 23 (28) |
| Late (stage III-IV) | 60 (72) |
| Histopathologic subtype, No. (%) | |
| Squamous cell carcinoma | 76 (92) |
| Site, No. (%) | |
| Oral cavity | 27 (33) |
| Oropharynx | 37 (45) |
| Laryngopharynx | 16 (19) |
| Other head and neck cancer | 3 (4) |
| Human papillomavirus type P16 positive, No. (%) | 29 (35) |
| Followed tumor board instructions, No. (%) | 63 (76) |
| Primary treatment, No. (%) | |
| Radiotherapy | 4 (5) |
| Chemoradiotherapy | 26 (31) |
| Chemotherapy | 2 (2) |
| Surgery | 51 (61) |
| Adjuvant treatment, No. (%) | |
| Any | 33 (40) |
| Radiotherapy | 16 (19) |
| Chemoradiotherapy | 16 (19) |
| Chemotherapy | 1 (1) |